Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2013 Aug 29.

Published in final edited form as: J Chem Inf Model. 2012 Jun 25;52(7):1886–1897. doi: 10.1021/ci300121p

(a) Ligand-receptor interaction diagram of peptidic matrix metalloproteinase inhibitor GM6001 cocrystallized with the anthrax toxin lethal factor (1PWU.pdb³⁶) (MOE 2010.10). (b) Additional ligand-receptor interaction map of GM6001 complexed with LF (1PWU.pdb³⁶) (PoseViewWeb⁶⁶). (c) Preliminary LF inhibitor pharmacophore model UA5 developed from the 2D enzyme-inhibitor interaction diagrams; green sphere = hydrophobic center; pink spheres = hydrogen-bond acceptors; blue sphere = hydrogenbond donor (visualized in MOE 2010.10).

(a) Ligand-receptor interaction diagram of peptidic matrix metalloproteinase inhibitor GM6001 cocrystallized with the anthrax toxin lethal factor (1PWU.pdb³⁶) (MOE 2010.10). (b) Additional ligand-receptor interaction map of GM6001 complexed with LF (1PWU.pdb³⁶) (PoseViewWeb⁶⁶). (c) Preliminary LF inhibitor pharmacophore model UA5 developed from the 2D enzyme-inhibitor interaction diagrams; green sphere = hydrophobic center; pink spheres = hydrogen-bond acceptors; blue sphere = hydrogenbond donor (visualized in MOE 2010.10).